MilliporeSigma Unveils €62M Flagship Facility for Superior Quality Control in Germany

MilliporeSigma, the North American life science division of Merck KGaA, Darmstadt, Germany, revealed plans to invest €62 million in constructing a new quality control facility at its Darmstadt headquarters. This initiative aims to consolidate about 135 employees from various departments into a modern, collaborative workspace. Spanning nearly 10,000 square meters, the building is expected to be finished by mid-2025. This project is part of a larger investment program at the Darmstadt site, where the company intends to allocate approximately €1.5 billion by 2025.

Robert Nass, head of quality & regulatory management, life science business of Merck KGaA said, “Quality plays an essential role in our purpose to impact life and health with science. The quality, compliance and business support are fundamental to our innovative Life Science products, services and digital offerings and make us a trusted partner to our stakeholders. Our new quality control facility is a reflection of our commitment to deliver the highest quality and safest products to our customers and the patients they serve.”

Designed to achieve the GOLD standard of the German Sustainable Building Council, the facility will incorporate self-sustaining regenerative energy generation and low-carbon construction practices. It will also adhere to stringent safety standards suitable for genetic engineering, biology laboratories, and dust-free environments that demand rigorous hygiene protocols. All laboratories will meet GMP (Good Manufacturing Practice) compliance guidelines.Darmstadt, Germany, holds significant strategic importance as a hub for life science technologies within the company. Over the next decade, approximately twenty percent of the business’s projected sales from new products are anticipated to originate from this location.